27 Days
Source:
اقتصاد سكاي نيوز عربية
M42 and Arsera to localize pharma in Abu Dhabi
M42 Company signed a memorandum of understanding with Arsera Life Sciences to promote the localization of biopharmaceutical industries in Abu Dhabi, with the aim of developing innovative therapeutic solutions, supporting research, and patient care. The collaboration focuses on leveraging genomic data and artificial intelligence to accelerate drug development and improve access to treatments, while also strengthening clinical research and the infrastructure for life sciences in the emirate. This partnership seeks to establish Abu Dhabi as a global hub for healthcare innovation and the pharmaceutical industry.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)